BFRI logo

Biofrontera (BFRI)

Profile

Full Name

Biofrontera Inc.

Ticker Symbol

BFRI

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

October 29, 2021

Indexes

Not included

Website

http://www.biofrontera-us.com

Employees

92

Key Details

Price

$0.86(+6.87%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$37.32M(+9.54% YoY)

Annual EPS

-$3.22(+75.27% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.86
BFRI price is $0.86

30-Day Relative Volume

0.69
BFRI 30-day relative volume is 0.69

Price Performance

Price Most recent change

+6.87%
BFRI price was up +6.87% on Apr 15, 2025

Price YTD change

-21.47%
BFRI price is down -21.47% since January 1st

Price 1-year change

-52.94%
BFRI price is down -52.94% year-on-year

Price 3-year change

-98.98%
BFRI price is down -98.98% over the past 3 years

Price Range

Price All-time high

$292.60
BFRI price is currently -99.71% below its historical high of $292.60

Price 3-year low

$0.61
BFRI price is currently +40.33% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$7.60M
BFRI market capitalization is $7.60 million

Market cap 3-year change

-89.43%
BFRI market capitalization is down -89.43% over the past 3 years

Market cap All-time high

$198.29M
BFRI market capitalization is currently -96.17% below its historical high of $198.29 million

Market cap sector rank

16.69%
BFRI market capitalization is higher than 16.69% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+74.36%
BFRI shares outstanding is up +74.36% year-on-year

Shares Outstanding 3-Year Change

+937.64%
BFRI shares outstanding is up +937.64% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.61
BFRI beta is 0.61

200-day SMA

$1.02
BFRI price is currently -16.46% below its 200-day simple moving average

50-day SMA

$0.95
BFRI price is currently -9.90% below its 50-day simple moving average

RSI

50.40
BFRI 14-day relative strength index is 50.40

Volume

0.69
BFRI 30-day relative volume is 0.69

ATR

$0.08
BFRI average true range is $0.08

10-day Historical Volatility

100.91%
BFRI 10-day historical volatility is 100.91%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$37.32M
BFRI annual revenue is $37.32 million

Revenue Analysts estimate

$43.38M
BFRI annual revenue is currently -13.98% lower than the consensus analysts' forecast

Revenue 1-year change

+9.54%
BFRI annual revenue is up +9.54% year-on-year

Revenue Sector rank

43.35%
BFRI annual revenue is higher than 43.35% of companies in Healthcare sector

EPS

EPS

-$3.22
BFRI annual earnings per share is -$3.22

EPS Analysts estimate

-$1.06
BFRI annual earnings per share is currently +203.77% higher than the consensus analysts' forecast

EPS 1-year change

+75.27%
BFRI annual earnings per share is up +75.27% year-on-year

EPS Sector rank

27.67%
BFRI annual earnings per share is higher than 27.67% of companies in Healthcare sector

Profit

Gross profit

$18.71M
BFRI annual gross profit is $18.71 million

Gross margin

50.14%
BFRI annual gross profit margin is 50.14%

Operating profit

-$17.21M
BFRI annual operating income is -$17.21 million

Operating margin

-46.11%
BFRI annual operating profit margin is -46.11%

Net income

-$17.76M
BFRI annual net profit is -$17.76 million

Net margin

-47.58%
BFRI annual net profit margin is -47.58%

Expenses

Total expenses

$54.53M
BFRI annual total expenses is $54.53 million

Operating expenses

$35.92M
BFRI annual total operating expenses is $35.92 million

Cost of goods sold

$18.61M
BFRI annual cost of goods sold is $18.61 million

Selling, general & administrative expenses

$33.84M
BFRI annual SGA is $33.84 million

Depreciation and amortization

$1.15M
BFRI annual depreciation & amortization is $1.15 million

Interest expense

$2.11M
BFRI annual interest expense is $2.11 million

Income tax

$22.00K
BFRI annual income tax is $22.00 thousand

EBIT & EBITDA

EBIT

-$15.63M
BFRI annual earnings before interest & taxes is -$15.63 million

EBITDA

-$14.48M
BFRI annual EBITDA is -$14.48 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$22.10M
BFRI annual total assets is $22.10 million

Non current assets

$1.40M
BFRI annual long term assets is $1.40 million

Current assets

$20.70M
BFRI annual total current assets is $20.70 million

Cash and cash equivalents

$5.91M
BFRI annual cash & cash equivalents is $5.91 million

Accounts receivable

$5.32M
BFRI annual accounts receivable is $5.32 million

Inventory

$6.65M
BFRI annual inventory is $6.65 million

Liabilities

Total liabilities

$17.67M
BFRI annual total liabilities is $17.67 million

Long term liabilities

$5.65M
BFRI annual total long term liabilities is $5.65 million

Current liabilities

$12.02M
BFRI annual total current liabilities is $12.02 million

Accounts payable

$1.86M
BFRI annual accounts payable is $1.86 million

Debt

Total debt

$4.92M
BFRI annual total debt is $4.92 million

Total debt 1-year change

-8.83%
BFRI annual total debt is down -8.83% year-on-year

Long term debt

$4.37M
BFRI annual long term debt is $4.37 million

Short term debt

$548.00K
BFRI annual short term debt is $548.00 thousand

Equity & Capital

Shareholders equity

$4.43M
BFRI annual stockholders equity is $4.43 million

Book value

$4.43M
BFRI annual book value is $4.43 million

Retained earnings

-$117.41M
BFRI annual retained earnings is -$117.41 million

Working capital

$8.68M
BFRI annual working capital is $8.68 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$10.27M
BFRI annual cash flow from operations is -$10.27 million

Cash from operations 1-year change

+58.75%
BFRI annual cash flow from operations is up +58.75% year-on-year

Cash from investing

-$3000.00
BFRI annual cash flow from investing activities is -$3000.00

Cash from investing 1-year change

-100.48%
BFRI annual cash flow from investing activities is down -100.48% year-on-year

Cash from financing

$14.84M
BFRI annual cash flow from financing activities is $14.84 million

Cash from financing 1-year change

+76.38%
BFRI annual cash flow from financing activities is up +76.38% year-on-year

CAPEX

CAPEX

$60.00K
BFRI annual capital expenditures is $60.00 thousand

CAPEX 1-year change

+1100%
BFRI annual capital expenditures is up +1100% year-on-year

Free Cash Flow

Free cash flow

-$10.33M
BFRI annual free cash flow is -$10.33 million

Free cash flow 1-year change

+58.51%
BFRI annual free cash flow is up +58.51% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

50.14%
BFRI annual gross profit margin is 50.14%

Operating margin

-46.11%
BFRI annual operating profit margin is -46.11%

Net margin

-47.58%
BFRI annual net profit margin is -47.58%

ROA & ROE

ROA

-70.99%
BFRI annual return on assets is -70.99%

ROE

-384.98%
BFRI annual return on equity is -384.98%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BFRI price to earnings ratio value is unknown

PE ratio Sector rank

-
BFRI price to earnings ratio is unknown

PB Ratio

PB ratio

1.71
BFRI price to book ratio is 1.71

PB ratio Sector rank

58.52%
BFRI price to book ratio is higher than 58.52% of companies in Healthcare sector

PS Ratio

PS ratio

0.20
BFRI price to sales ratio is 0.20

PS ratio Sector rank

7.44%
BFRI price to sales ratio is higher than 7.44% of companies in Healthcare sector

Enterprise value

Enterprise value

$6.61M
BFRI enterprise value is $6.61 million

Enterprise value Sector rank

20.76%
BFRI enterprise value is higher than 20.76% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.46
BFRI EV/EBITDA is -0.46

EV/EBITDA Sector rank

52.65%
BFRI EV/EBITDA is higher than 52.65% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.72
BFRI annual current ratio is 1.72

Quick ratio

1.17
BFRI annual quick ratio is 1.17

Leverage

Debt to equity

0.92
BFRI annual debt to equity ratio is 0.92

Interest coverage ratio

-7.42
BFRI annual interest coverage ratio is -7.42

Risk & Stability

Piotroski F-Score

4
BFRI piotroski f-score is 4

Altman Z-Score

-7.35
BFRI altman z-score is -7.35

Analyst ratings

Recent major analysts updates

Nov 15, 24 Benchmark
Buy
Aug 16, 24 Benchmark
Buy
Aug 31, 23 Benchmark
Buy

Institutional Ownership

Similar stocks

CANF logo
Can-Fite BioPharma (CANF)
CHRO logo
Channel Therapeutics (CHRO)
MYNZ logo
Mainz Biomed BV (MYNZ)
INDP logo
Indaptus Therapeutics (INDP)
BGXX logo
Bright Green (BGXX)
ADXN logo
Addex Therapeutics Ltd (ADXN)
Dogwood Therapeutics (DWTX)
MHUA logo
Meihua International Medical Technologies Co (MHUA)
COSM logo
Cosmos Health (COSM)
  • What is the ticker symbol for Biofrontera?
  • Does Biofrontera pay dividends?
  • What sector is Biofrontera in?
  • What industry is Biofrontera in?
  • What country is Biofrontera based in?
  • When did Biofrontera go public?
  • Is Biofrontera in the S&P 500?
  • Is Biofrontera in the NASDAQ 100?
  • Is Biofrontera in the Dow Jones?
  • When was Biofrontera's last earnings report?
  • When does Biofrontera report earnings?
  • Should I buy Biofrontera stock now?

What is the ticker symbol for Biofrontera?

The ticker symbol for Biofrontera is NASDAQ:BFRI

Does Biofrontera pay dividends?

No, Biofrontera does not pay dividends

What sector is Biofrontera in?

Biofrontera is in the Healthcare sector

What industry is Biofrontera in?

Biofrontera is in the Drug Manufacturers - Specialty & Generic industry

What country is Biofrontera based in?

Biofrontera is headquartered in United States

When did Biofrontera go public?

Biofrontera's initial public offering (IPO) was on October 29, 2021

Is Biofrontera in the S&P 500?

No, Biofrontera is not included in the S&P 500 index

Is Biofrontera in the NASDAQ 100?

No, Biofrontera is not included in the NASDAQ 100 index

Is Biofrontera in the Dow Jones?

No, Biofrontera is not included in the Dow Jones index

When was Biofrontera's last earnings report?

Biofrontera's most recent earnings report was on Aug 12, 2022

When does Biofrontera report earnings?

The date for Biofrontera's next earnings report has not been announced yet

Should I buy Biofrontera stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page